Project Details
Projekt Print View

New avenues of multiple sclerosis treatment inspired by pregnancy

Applicant Dr. Max Kaufmann
Subject Area Molecular and Cellular Neurology and Neuropathology
Term from 2021 to 2022
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 456055931
 
Final Report Year 2023

Final Report Abstract

Multiple sclerosis (MS) is an autoimmune disease that attacks the brain and spinal cord tissue of young patients and often leads to progressive disability over the course of many years. Despite the use of highly effective immunomodulatory therapies, it is still largely unknown why neurons cannot be protected from damage in MS - not least because a detailed description of this process in brain tissue is difficult. In the present work, we use a new sequencing technology that allows us to visualise the expression of thousands of genes directly in the brain tissue of deceased MS patients with high spatial resolution and to break down the pathological processes of progressive neurodegeneration in detail. On this basis, we were able to identify a previously unknown relation between the loss of growth factors in the brains of patients with progressive MS and the progressive loss of nerve cells. To lay the groundwork for future therapies to address this mechanism, we have prioritised new molecular targets. The work has been published in Nature Neuroscience.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung